Literature DB >> 16556027

Notch signaling in T-cell acute lymphoblastic leukemia.

Andrew P Weng1, Arthur Lau.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is a form of pediatric leukemia that is thought to be caused by approximately 12 distinct chromosomal translocations that lead to aberrant expression of as many different cellular genes. Development of novel, rational therapies against such a diverse set of mechanistic targets has thus been a formidable challenge. Recent studies, however, have identified a large fraction of T-ALL cases carrying mutations in one of these genes, Notch1, suggesting for the first time that many cases may share a common pathogenic etiology, and perhaps may allow the development of targeted therapies that benefit the majority of patients with this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16556027     DOI: 10.2217/14796694.1.4.511

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  10 in total

Review 1.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

Review 2.  An overview of notch signaling in adult tissue renewal and maintenance.

Authors:  Chihiro Sato; Guojun Zhao; Ma Xenia G Ilagan
Journal:  Curr Alzheimer Res       Date:  2012-02       Impact factor: 3.498

3.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs.

Authors:  Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul H Sarkar
Journal:  Drug Deliv Transl Res       Date:  2013-04-01       Impact factor: 4.617

4.  Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.

Authors:  Vishva Mitra Sharma; Jennifer A Calvo; Kyle M Draheim; Leslie A Cunningham; Nicole Hermance; Levi Beverly; Veena Krishnamoorthy; Manoj Bhasin; Anthony J Capobianco; Michelle A Kelliher
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

Review 5.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

6.  Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.

Authors:  Jennifer J Hofmann; Ann C Zovein; Huilin Koh; Freddy Radtke; Gerry Weinmaster; M Luisa Iruela-Arispe
Journal:  Development       Date:  2010-12       Impact factor: 6.868

Review 7.  Notch inhibitors as a new tool in the war on cancer: a pathway to watch.

Authors:  Benjamin Purow
Journal:  Curr Pharm Biotechnol       Date:  2009-02       Impact factor: 2.837

8.  Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.

Authors:  O H Ng; Y Erbilgin; S Firtina; T Celkan; Z Karakas; G Aydogan; E Turkkan; Y Yildirmak; C Timur; E Zengin; J J M van Dongen; F J T Staal; U Ozbek; M Sayitoglu
Journal:  Blood Cancer J       Date:  2014-03-14       Impact factor: 11.037

9.  N3ICD with the transmembrane domain can effectively inhibit EMT by correcting the position of tight/adherens junctions.

Authors:  Junyu Tan; Xixun Zhang; Wenjun Xiao; Xiong Liu; Chun Li; Yuxian Guo; Wei Xiong; Yaochen Li
Journal:  Cell Adh Migr       Date:  2019-12       Impact factor: 3.405

10.  Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family.

Authors:  Lei Wang; Fangchun Jin; An Qin; Yongqiang Hao; Yufeng Dong; Shengfang Ge; Kerong Dai
Journal:  Mol Cancer       Date:  2014-06-03       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.